MT
Myris Therapeutics
InactiveBioHybrid Solutions develops nanoarmored protein-polymer conjugates to enhance the stability and efficacy of therapeutic proteins. This technology addresses the challenges of protein degradation and delivery, improving treatment outcomes in biopharmaceutical applications.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- BioHybrid Solutions develops nanoarmored protein-polymer conjugates to enhance the stability and efficacy of therapeutic proteins. This technology addresses the challenges of protein degradation and delivery, improving treatment outcomes in biopharmaceutical applications.